Literature DB >> 9016559

Cell-type specific DNA-protein interactions at the tissue-type plasminogen activator promoter in human endothelial and HeLa cells in vivo and in vitro.

J Arts1, I Herr, M Lansink, P Angel, T Kooistra.   

Abstract

Tissue-type plasminogen activator (t-PA) gene expression in human endothelial cells and HeLa cells is stimulated by the protein kinase C activator phorbol 12-myristate 13-acetate (PMA) at the level of transcription. To study the mechanism of transcriptional regulation, we have characterized a segment of the t-PA gene extending from -135 to +100 by in vivo footprinting analysis [dimethyl sulphate (DMS) method] and gel mobility shift assay. In vivo footprinting analysis revealed changes in cleavage pattern in five distinct promoter elements in both endothelial cells and HeLa cells, including a PMA-responsive element (TRE), a CTF/NF-1 binding site and three GC-boxes, and an altered cleavage pattern of the TRE and CTF/NF-1 element after PMA treatment of HeLa cells. Although endothelial cells and HeLa cells differed in the exact G residues protected by nuclear proteins,in vitro bandshift analysis showed that nuclear protein binding to the t-PA promoter was qualitatively and quantitatively very similar in both cell types, except for the TRE. Protein binding to the TRE under non- stimulated conditions was much higher in human endothelial cells than in HeLa cells, and this TRE-bound protein showed a lower dissociation rate in the endothelial cells than in HeLa cells. In endothelial cells, the proteins bound to the TRE consisted mainly of the AP-1 family members JunD and Fra-2, while in HeLa cells predominantly JunD, FosB and Fra-2 were bound. The proteins bound to the other protected promoter elements were identified as SP-1 (GC-box II and III) and CTF/NF-1 (CTF/NF-1 binding site). After PMA treatment of the cells, AP-1 and SP-1 binding was increased two-fold in endothelial cell nuclear extracts and >20-fold in HeLa nuclear extracts. In the endothelial cells, all Jun and Fos forms (c-Jun, JunB, JunD, c-Fos, FosB, Fra-1 and Fra-2) were part of the AP-1 complex after PMA induction. In HeLa cells, the complex consisted predominantly of c-Jun and the Fos family members FosB and Fra-2. In the light of previous studies involving mutational analysis of the human and murine t-PA promoter our results underline an important role of the five identified promoter regions in basal and PMA-stimulated t-PA gene expression in intact human endothelial cells and HeLa cells. The small differences in DMS protection pattern and differences in the individual AP-1 components bound in endothelial cells and HeLa cells point to subtle cell-type specific differences in t-PA gene regulation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9016559      PMCID: PMC146448          DOI: 10.1093/nar/25.2.311

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  28 in total

1.  In vivo footprinting of a muscle specific enhancer by ligation mediated PCR.

Authors:  P R Mueller; B Wold
Journal:  Science       Date:  1989-11-10       Impact factor: 47.728

2.  Role of protein kinase C and cyclic adenosine monophosphate in the regulation of tissue-type plasminogen activator, plasminogen activator inhibitor-1, and platelet-derived growth factor mRNA levels in human endothelial cells. Possible involvement of proto-oncogenes c-jun and c-fos.

Authors:  T Kooistra; P J Bosma; K Toet; L H Cohen; M Griffioen; E van den Berg; L le Clercq; V W van Hinsbergh
Journal:  Arterioscler Thromb       Date:  1991 Jul-Aug

Review 3.  Basic and clinical aspects of fibrinolysis and thrombolysis.

Authors:  D Collen; H R Lijnen
Journal:  Blood       Date:  1991-12-15       Impact factor: 22.113

4.  Regulation of endothelial tissue plasminogen activator and plasminogen activator inhibitor type 1 synthesis by diacylglycerol, phorbol ester, and thrombin.

Authors:  J Grulich-Henn; G Müller-Berghaus
Journal:  Blut       Date:  1990-07

5.  Cyclic AMP potentiates phorbol ester stimulation of tissue plasminogen activator release and inhibits secretion of plasminogen activator inhibitor-1 from human endothelial cells.

Authors:  L Santell; E G Levin
Journal:  J Biol Chem       Date:  1988-11-15       Impact factor: 5.157

6.  Transcription factor Sp1 is important for retinoic acid-induced expression of the tissue plasminogen activator gene during F9 teratocarcinoma cell differentiation.

Authors:  A L Darrow; R J Rickles; L T Pecorino; S Strickland
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

7.  In vitro analysis of the tissue plasminogen activator promoter reveals a GC box-binding activity present in murine brain but undetectable in kidney and liver.

Authors:  L T Pecorino; A L Darrow; S Strickland
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

8.  A DNA motif related to the cAMP-responsive element and an exon-located activator protein-2 binding site in the human tissue-type plasminogen activator gene promoter cooperate in basal expression and convey activation by phorbol ester and cAMP.

Authors:  R L Medcalf; M Rüegg; W D Schleuning
Journal:  J Biol Chem       Date:  1990-08-25       Impact factor: 5.157

9.  Differentiation-responsive elements in the 5' region of the mouse tissue plasminogen activator gene confer two-stage regulation by retinoic acid and cyclic AMP in teratocarcinoma cells.

Authors:  R J Rickles; A L Darrow; S Strickland
Journal:  Mol Cell Biol       Date:  1989-04       Impact factor: 4.272

10.  IP-1: a dominant inhibitor of Fos/Jun whose activity is modulated by phosphorylation.

Authors:  J Auwerx; P Sassone-Corsi
Journal:  Cell       Date:  1991-03-08       Impact factor: 41.582

View more
  9 in total

1.  The plasmin system is induced by and degrades amyloid-beta aggregates.

Authors:  H M Tucker; M Kihiko; J N Caldwell; S Wright; T Kawarabayashi; D Price; D Walker; S Scheff; J P McGillis; R E Rydel; S Estus
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

2.  The transcriptional response to hypoxic insult controlled by FRA-2.

Authors:  Tanya L Butler; Keith R Pennypacker
Journal:  Gene Expr       Date:  2005

3.  Fra-1 induces morphological transformation and increases in vitro invasiveness and motility of epithelioid adenocarcinoma cells.

Authors:  O Kustikova; D Kramerov; M Grigorian; V Berezin; E Bock; E Lukanidin; E Tulchinsky
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

4.  Role of histone acetylation in the stimulatory effect of valproic acid on vascular endothelial tissue-type plasminogen activator expression.

Authors:  Pia Larsson; Erik Ulfhammer; Mia Magnusson; Niklas Bergh; Sebastian Lunke; Assam El-Osta; Robert L Medcalf; Per-Arne Svensson; Lena Karlsson; Sverker Jern
Journal:  PLoS One       Date:  2012-02-20       Impact factor: 3.240

5.  Species-Specific Regulation of t-PA and PAI-1 Gene Expression in Human and Rat Astrocytes.

Authors:  Anna Tjärnlund-Wolf; Karin Hultman; Fredrik Blomstrand; Michael Nilsson; Robert L Medcalf; Christina Jern
Journal:  Gene Regul Syst Bio       Date:  2014-05-08

6.  Dependence of Proximal GC Boxes and Binding Transcription Factors in the Regulation of Basal and Valproic Acid-Induced Expression of t-PA.

Authors:  Erik Ulfhammer; Pia Larsson; Mia Magnusson; Lena Karlsson; Niklas Bergh; Sverker Jern
Journal:  Int J Vasc Med       Date:  2016-02-07

7.  Effect of Regulatory Element DNA Methylation on Tissue-Type Plasminogen Activator Gene Expression.

Authors:  Sylvie Dunoyer-Geindre; Anne-Sophie Rivier-Cordey; Carlos Caetano; Richard J Fish; Egbert K O Kruithof
Journal:  PLoS One       Date:  2016-12-14       Impact factor: 3.240

8.  Dual mechanisms for the regulation of brain-derived neurotrophic factor by valproic acid in neural progenitor cells.

Authors:  Hyun Myung Ko; Yeonsun Jin; Hyun Ho Park; Jong Hyuk Lee; Seung Hyo Jung; So Young Choi; Sung Hoon Lee; Chan Young Shin
Journal:  Korean J Physiol Pharmacol       Date:  2018-10-25       Impact factor: 2.016

9.  Sp1/3 and NF-1 mediate basal transcription of the human P2X1 gene in megakaryoblastic MEG-01 cells.

Authors:  Jiangqin Zhao; Steven J Ennion
Journal:  BMC Mol Biol       Date:  2006-03-10       Impact factor: 2.946

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.